Actuate Therapeutics, Inc (ACTU) - Company Cash Volume

Corporate emblem and logo of actuatetherapeutics.com (ACTU)

Actuate Therapeutics, Inc. (ACTU) is currently in the molecule testing stage, which entails significant laboratory expenses and a lack of scalability. This cash balance chart visualizes current liquidity, where the 0.00 metric determines the parameter status. The company relies on investments to develop targeted cancer treatments, although high trial costs and FDA risks pose threats to its financial stability.

Actuate Therapeutics Inc - ACTU Company Cash Balance (period 08/14/2024 - 11/21/2026)

Financial and market metric breakdowns for Actuate Therapeutics (ACTU)

Analysis of all company metrics:ACTU Actuate Therapeutics, Inc.
Brand item of actuatetherapeutics.com

Analyzing the financial reserves of Actuate Therapeutics, Inc. (ACTU) is critical for assessing its resilience to market shocks. Developing an oncology ecosystem based on GSK-3 inhibitors requires colossal R&D investments. Monitoring the volume of highly liquid cash allows for a correlation between the capital burn rate and the efficiency of capital expenditures. A stable liquidity balance confirms the company's ability to complete the integration of innovative protocols without risking business degradation.

Direct competitors

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds